Per the ASCO initial recommendations (26), in patients with de-novo hypothyroidism thyroid hormone therapy should be initiated as in non-immune related thyroid diseases (1.6 mcg/kg/d or a starting dose of 50 mcg for elderly patients). This evidence concerns the gene TG and hypothyroidism.